Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma

Front Pediatr. 2022 Aug 5:10:949950. doi: 10.3389/fped.2022.949950. eCollection 2022.

Abstract

Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm associated with the Kasabach-Merritt phenomenon (KMP), which is a consumptive coagulopathy with associated potentially life-threatening thrombocytopenia. There are no standardized treatment protocols for the management of KHE with KMP. Moreover, there are limited reports regarding the treatment of cases of rebound. Herein, we describe a rare case of rebound of KHE/KMP, during systemic sirolimus treatment, successfully treated with embolization and vincristine infusion combined with microwave ablation.

Keywords: Kasabach-Merritt phenomenon; ablation; embolization; kaposiform hemangioendothelioma; prognosis; vincristine.

Publication types

  • Case Reports